Clinical Trial Update: Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.

View source ↗

Summary

A completed multicenter study validates a novel bio-anatomical staging system to predict survival and tailor adjuvant therapy for esophageal squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sichuan University | Conditions: ESCC | Status: COMPLETED